
Contraline
Developer of a male contraceptive product intended to provide non-surgical and reversible birth control procedures. The company's technology implants a non-hormonal, non-surgical, and reversible polym...
Valuation
$60M
Latest known
Share Price
N/A
Total Raised
$41.7M
Last Round
N/A